1. Home
  2. CLNN

CLNN

Clene Inc.

Logo Clene Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).

Founded: 2012 Country:
United States
United States
Employees: N/A City: SALT LAKE CITY
Market Cap: 53.1M IPO Year: N/A
Target Price: $7.20 AVG Volume (30 days): 922.3K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.47 EPS Growth: N/A
52 Week Low/High: $0.25 - $1.09 Next Earning Date: 05-10-2024
Revenue: $654,000 Revenue Growth: 38.27%
Revenue Growth (this year): -30.75% Revenue Growth (next year): 1129.69%

Share on Social Networks: